Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Lepu Medical Technology (Beijing) Co., Ltd.

http://en.lepumedical.com/

Latest From Lepu Medical Technology (Beijing) Co., Ltd.

Zymeworks’ HER2 Antibody Hits Target In Pivotal Biliary Tract Cancer Trial

Bookmark
  • News
By Ayisha Sharma

The Canadian firm’s bispecific antibody asset improved response rates in advanced biliary tract cancer patients, potentially setting it up to become the first HER2-targeted drug approved for the disease.

Clinical Trials Cancer

Medtech 100: Big Three Companies Lead From The Front With Medtech Back On Solid Growth Footing

Bookmark
  • Analysis
By Ashley Yeo

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Medtech 100 Commercial

Big Three Lead From The Front With Medtech Back On Solid Growth Footing

Bookmark
  • Analysis
By Ashley Yeo

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Outlook 2023 Sales & Earnings

Pfizer Signs Paxlovid Agreement As China Cases Soar

Bookmark
  • News
By Brian Yang

Pfizer has signed up with a state-owned enterprise for the distribution of its recently approved oral antiviral for COVID-19 in China, where daily case counts are surging amid some tightening restrictions.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Other Names / Subsidiaries
    • Beijing Star Medical Devices Co., Ltd (Star Medical)
    • Beijing Target Medical Technologies, Ltd (Target Medical)
    • Lepu and Shaanxi Qinming Medical Co., Ltd.(Qinming Medical)
    • Lepu Science & Technology Co., Ltd. (Lepu Technology)
    • Medical Equipment Co., Ltd (Lepu Equipemnt)
    • Shanghai Shape Memory Alloy Co.,Ltd (SHSMA)
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By